EurOPDX members awarded ITN grant to train a new generation of brain cancer researchers

Glioblastoma (GBM), an aggressive and devastating form of brain tumour, will be the focus of the new four-year project GLIOTRAIN just awarded a 3.9 million euros grant from the European Commission’s Horizon 2020 Marie Sklodowska-Curie Innovative Training Network (ITN) initiative. The project, co-ordinated by EurOPDX member Prof. Annette Byrne of the Royal College of Surgeons in Ireland (RCSI) will address the urgent need to identify new treatments for GBM, whilst also aiming to unravel disease resistance mechanisms through state-of-the-art genomics and systems medicine approaches. Taking a multi-pronged approach, GLIOTRAIN will foster the next generation of young scientists, supporting 15 PhD projects in areas including medical oncology, computational biology, and immunotherapy. This multi-sectoral industry-academia collaboration also includes EurOPDX member Prof. Simone Niclou from the Luxembourg Institute of Health (LIH), and will employ advanced PDX models of GBM in its research. EurOPDX congratulates Prof. Annette Byrne and Simone Niclou and all GLIOTRAIN partners for their success, and eagerly awaits the results of this young and promising network of future brain cancer research leaders. GLIOTRAIN website: